SCHEMBL8518522

SCHEMBL8518522

NCCNC(N)=S

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15344088 0.83 ALDH1A1 (0.48)
SCHEMBL2932685 0.82
SCHEMBL2254856 0.79
SCHEMBL17415916 0.78 PAOX (0.52)
SCHEMBL11809606 0.78 PAOX (0.52)
SCHEMBL15328412 0.78 ALDH1A1 (0.43)
SCHEMBL10462001 0.78 ALDH1A1 (0.60)
SCHEMBL3360813 0.75
SCHEMBL16024409 0.75 CA1 (0.42)
SCHEMBL21127531 0.75 CA1 (0.42)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-11269149-A None JP disclosed
US-20230322815-A1 NOVEL COMPOUNDS AND THERAPEUTIC USES THEREOF UNIVERSITY OF HUDDERSFIELD (GB) 2023-10-12 US disclosed
CN-109134704-A A kind of application of chitosan oligosaccharide thiourea derivatives, nano silver prepared therefrom and the nano silver 河南农业大学 2019-01-04 CN disclosed
CN-1284073-A 5- (2-imidazolinylamino) -benzimidazole derivatives, their preparation and their use as alpha-adrenergic receptor agonists with improved metabolic stability PROCTER & GAMBLE (US) 2001-02-14 CN disclosed
JP-H11269149-A PRODUCTION OF 2-IMINOIMIDAZOLIDINES SHIRATORI SEIYAKU KK 1999-10-05 JP disclosed
EP-0549755-A4 1994-03-30 EP disclosed
EP-0549755-A1 ddI IMMUNOASSAYS, DERIVATIVES, CONJUGATES AND ANTIBODIES SIGMA CHEMICAL COMPANY (US) 1993-07-07 EP disclosed
WO-1992022639-A1 ddI IMMUNOASSAYS, DERIVATIVES, CONJUGATES AND ANTIBODIES SIGMA CHEMICAL COMPANY (US) 1992-12-23 WO disclosed